339 related articles for article (PubMed ID: 23150057)
1. New opportunities from the cancer metabolome.
Aboud OA; Weiss RH
Clin Chem; 2013 Jan; 59(1):138-46. PubMed ID: 23150057
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics approaches and applications in prostate cancer research.
Zhang A; Yan G; Han Y; Wang X
Appl Biochem Biotechnol; 2014 Sep; 174(1):6-12. PubMed ID: 24838846
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics: a revolution for novel cancer marker identification.
Bu Q; Huang Y; Yan G; Cen X; Zhao YL
Comb Chem High Throughput Screen; 2012 Mar; 15(3):266-75. PubMed ID: 22221059
[TBL] [Abstract][Full Text] [Related]
4. 18O-assisted dynamic metabolomics for individualized diagnostics and treatment of human diseases.
Nemutlu E; Zhang S; Juranic NO; Terzic A; Macura S; Dzeja P
Croat Med J; 2012 Dec; 53(6):529-34. PubMed ID: 23275318
[TBL] [Abstract][Full Text] [Related]
5. Mass spectrometry based proteomics and metabolomics in personalized oncology.
Kowalczyk T; Ciborowski M; Kisluk J; Kretowski A; Barbas C
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165690. PubMed ID: 31962175
[TBL] [Abstract][Full Text] [Related]
6. Metabolomics enables precision medicine: "A White Paper, Community Perspective".
Beger RD; Dunn W; Schmidt MA; Gross SS; Kirwan JA; Cascante M; Brennan L; Wishart DS; Oresic M; Hankemeier T; Broadhurst DI; Lane AN; Suhre K; Kastenmüller G; Sumner SJ; Thiele I; Fiehn O; Kaddurah-Daouk R;
Metabolomics; 2016; 12(10):149. PubMed ID: 27642271
[TBL] [Abstract][Full Text] [Related]
7. Systematic biobanking, novel imaging techniques, and advanced molecular analysis for precise tumor diagnosis and therapy: The Polish MOBIT project.
Niklinski J; Kretowski A; Moniuszko M; Reszec J; Michalska-Falkowska A; Niemira M; Ciborowski M; Charkiewicz R; Jurgilewicz D; Kozlowski M; Ramlau R; Piwkowski C; Kwasniewski M; Kaczmarek M; Ciereszko A; Wasniewski T; Mroz R; Naumnik W; Sierko E; Paczkowska M; Kisluk J; Sulewska A; Cybulski A; Mariak Z; Kedra B; Szamatowicz J; Kurzawa P; Minarowski L; Charkiewicz AE; Mroczko B; Malyszko J; Manegold C; Pilz L; Allgayer H; Abba ML; Juhl H; Koch F;
Adv Med Sci; 2017 Sep; 62(2):405-413. PubMed ID: 28646744
[TBL] [Abstract][Full Text] [Related]
8. [Gastroenterological Cancer Diagnosis by Metabolomics-Discovery of Pancreatic Cancer Biomarker].
Yoshida M; Nishiumi S; Azuma T
Rinsho Byori; 2015 Apr; 63(4):450-6. PubMed ID: 26536778
[TBL] [Abstract][Full Text] [Related]
9. Clinical applications of metabolomics in oncology: a review.
Spratlin JL; Serkova NJ; Eckhardt SG
Clin Cancer Res; 2009 Jan; 15(2):431-40. PubMed ID: 19147747
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics for mitochondrial and cancer studies.
Nagrath D; Caneba C; Karedath T; Bellance N
Biochim Biophys Acta; 2011 Jun; 1807(6):650-63. PubMed ID: 21420931
[TBL] [Abstract][Full Text] [Related]
11. [Possibility of Metabolite Biomarkers for Early Detection of Cancer].
Nishiumi S; Yoshida M
Gan To Kagaku Ryoho; 2018 Jun; 45(6):894-898. PubMed ID: 30026409
[TBL] [Abstract][Full Text] [Related]
12. Metabolomics in diagnosis and biomarker discovery of colorectal cancer.
Zhang A; Sun H; Yan G; Wang P; Han Y; Wang X
Cancer Lett; 2014 Apr; 345(1):17-20. PubMed ID: 24333717
[TBL] [Abstract][Full Text] [Related]
13. Pharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets.
Corona G; Rizzolio F; Giordano A; Toffoli G
J Cell Physiol; 2012 Jul; 227(7):2827-31. PubMed ID: 22105661
[TBL] [Abstract][Full Text] [Related]
14. Proteomics and Metabolomics Approaches towards a Functional Insight onto AUTISM Spectrum Disorders: Phenotype Stratification and Biomarker Discovery.
Ristori MV; Mortera SL; Marzano V; Guerrera S; Vernocchi P; Ianiro G; Gardini S; Torre G; Valeri G; Vicari S; Gasbarrini A; Putignani L
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872562
[TBL] [Abstract][Full Text] [Related]
15. Metabolomics as a Challenging Approach for Medicinal Chemistry and Personalized Medicine.
Frédérich M; Pirotte B; Fillet M; de Tullio P
J Med Chem; 2016 Oct; 59(19):8649-8666. PubMed ID: 27295417
[TBL] [Abstract][Full Text] [Related]
16. Innovation in metabolomics to improve personalized healthcare.
Cacciatore S; Loda M
Ann N Y Acad Sci; 2015 Jun; 1346(1):57-62. PubMed ID: 26014591
[TBL] [Abstract][Full Text] [Related]
17. The Relevance of Mass Spectrometry Analysis for Personalized Medicine through Its Successful Application in Cancer "Omics".
Ciocan-Cartita CA; Jurj A; Buse M; Gulei D; Braicu C; Raduly L; Cojocneanu R; Pruteanu LL; Iuga CA; Coza O; Berindan-Neagoe I
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31130665
[TBL] [Abstract][Full Text] [Related]
18. Metabolomics in pancreatic cancer biomarkers research.
Tumas J; Kvederaviciute K; Petrulionis M; Kurlinkus B; Rimkus A; Sakalauskaite G; Cicenas J; Sileikis A
Med Oncol; 2016 Dec; 33(12):133. PubMed ID: 27807722
[TBL] [Abstract][Full Text] [Related]
19. Metabolomics Applications in Precision Medicine: An Oncological Perspective.
Puchades-Carrasco L; Pineda-Lucena A
Curr Top Med Chem; 2017; 17(24):2740-2751. PubMed ID: 28685691
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]